Avalon Pharmaceuticals

About Avalon Pharmaceuticals

Established in 1998 in Riyadh, Saudi Arabia, Avalon Pharma operates as a manufacturer and marketer of consumer health brands and generic prescription medicines. Initially founded as the Middle East Factory For Chemical Products, the company, led by founder Ahmad S Al Tabbaa, commenced operations with its first facility, "Avalon 1". The company has since expanded its footprint with multiple manufacturing facilities, including an R&D center, and now exports to several countries in the MENA region, Eastern Europe, Asia, and Africa. In early 2024, Avalon Pharma became a publicly traded entity, launching its initial public offering on the Saudi Stock Exchange (Tadawul).

The company's business model encompasses the development, manufacturing, and distribution of its product portfolio through a network that includes large retailers, pharmacy chains, and international sub-distributors. Revenue generation is driven by direct sales, in-licensing agreements to market new products, out-licensing of its formulations, and contract manufacturing services for other pharmaceutical companies. A significant portion of its business comes from public tenders, reflecting a strong relationship with government healthcare entities in Saudi Arabia. Dermatological and skin care products account for approximately 50% of the company's total revenue.

Avalon Pharma's product offerings consist of over 70 brands with more than 300 SKUs, covering a wide range of therapeutic areas. Key categories include dermatologicals, respiratory care, cardiovascular health, and central nervous system medications. The company holds a prominent market position in Saudi Arabia, ranking first in the dermatology segment and among the top five in respiratory care. Its portfolio includes both over-the-counter (OTC) products and prescription drugs, with well-known brands such as Avogain for hair loss and a variety of skincare and brightening products. The company's growth strategy includes expanding into high-tech medications like oncology and general injectables.